Lorglumide is a highly effective competitive ligand for the cholecystokinine-A receptor (CCKRA). References: Sturzu A, Sheikh S, Klose U, Echner H, Kalbacher H, Deeg M, Nagele T, Horger M, Schwentner C, Ernemann U, Heckl S. Potential of the gastric motility drug lorglumide in prostate cancer imaging. Eur J Pharm Sci. 2012 Apr 11;45(5):575-80. doi: 10.1016/j.ejps.2011.12.011. Epub 2011 Dec 30. PubMed PMID: 22226647.

纯度：≥98%

CAS：97964-56-2